ERBB2 and breast carcinoma: In this sense, a nanohybrid of mesoporous silica with carbon loaded with doxorubicin and targeted with HB5 aptamer, found a significant improvement in cell uptake and cytotoxic activity over HER2-positive breast cancer cells, by specific interactions with HER2 cell membrane receptor [75].